Drugs Made In America Acquisition (DMIIR) Cash from Operations (2025)
Drugs Made In America Acquisition (DMIIR) posted quarterly Cash from Operations of 314864.0 for Q4 2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIR) Cash from Operations (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Cash from Operations for 1 consecutive years, with 314864.0 the latest figure, recorded in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - | - |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - | - |
| 4 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - | -34,137.00 |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - | -100,073.00 |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - | -162,173.00 |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - | - |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - | -292,266.00 |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - | - |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -314,864.00 |
| Sep 30, 2025 | -690,726.00 |